Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Make a Bundle on $SINA

Sina Corporation (SINA) jumped by over 18% Thursday when it shot from $78.48 at close of trading Wednesday to finish the  day at $94.23. Bloomberg reports, “Sina Corp., the owner of the Twitter-like Weibo service in China, rose the most in three months after a senior government official encouraged agencies to use microblogs for information disclosure.” Several hedge funds made a bundle on the increase:

COATUE MANAGEMENT

1. Coatue Management – Philippe Laffont: Gained $39.7 million

2. Jat Capital Management – John Thaler: Gained $33.5 million

3. Brookside Capital – Bain Capital: Gained $8.6 million

4. Criterion Capital – Christopher Lord: Gained $8.5 million

5. Tremblant Capital – Brett Barakett: Gained $6.2 million

6. Luxor Capital Group – Christian Leone: Gained $5.2 million

7. Sac Capital Advisors – Steven Cohen: Gained $4.6 million

8. Joho Capital – Robert Karr: Gained $4.0 million

9. Clough Capital Partners – Charles Clough: Gained $3.2 million

10. Crosslink Capital – Seymour Sy Kaufman and Michael Stark: Gained $2.9 million

DISCLAIMER: These calculations assume that these hedge funds did not increase or reduce their stock positions in SINA since the end of June. We did not take into account their option positions.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!